Oric Pharmaceuticals IncNASDAQ:ORIC
- LAST PRICE7.4900
- TODAY'S CHANGE (%)-0.1900 (-2.4740%)
- Bid / Lots7.2500/ 3
- Ask / Lots8.0400/ 1
- Open / Previous Close7.5900 / 7.6800
- Day Range
- 52 Week Range
- Volume448,411
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ORIC |
|---|---|---|
| 09:32 ET | 5892 | 7.81 |
| 09:34 ET | 200 | 7.8 |
| 09:36 ET | 18084 | 7.64 |
| 09:39 ET | 1364 | 7.74 |
| 09:41 ET | 900 | 7.65 |
| 09:43 ET | 5898 | 7.55 |
| 09:45 ET | 400 | 7.61 |
| 09:50 ET | 100 | 7.585 |
| 09:52 ET | 1516 | 7.49 |
| 09:54 ET | 420 | 7.54 |
| 09:57 ET | 102 | 7.57 |
| 09:59 ET | 500 | 7.53 |
| 10:01 ET | 2857 | 7.53 |
| 10:03 ET | 200 | 7.5 |
| 10:06 ET | 100 | 7.48 |
| 10:08 ET | 2564 | 7.51 |
| 10:12 ET | 600 | 7.49 |
| 10:14 ET | 100 | 7.515 |
| 10:15 ET | 1300 | 7.48 |
| 10:17 ET | 100 | 7.48 |
| 10:19 ET | 555 | 7.48 |
| 10:24 ET | 1322 | 7.5 |
| 10:26 ET | 100 | 7.5 |
| 10:28 ET | 900 | 7.48 |
| 10:30 ET | 100 | 7.5 |
| 10:32 ET | 1296 | 7.53 |
| 10:33 ET | 100 | 7.53 |
| 10:35 ET | 400 | 7.55 |
| 10:37 ET | 100 | 7.55 |
| 10:39 ET | 1300 | 7.52 |
| 10:42 ET | 1462 | 7.52 |
| 10:44 ET | 2109 | 7.566 |
| 10:46 ET | 700 | 7.54 |
| 10:50 ET | 900 | 7.56 |
| 10:51 ET | 200 | 7.56 |
| 10:53 ET | 1600 | 7.54 |
| 10:55 ET | 200 | 7.53 |
| 10:57 ET | 100 | 7.53 |
| 11:00 ET | 628 | 7.56 |
| 11:06 ET | 811 | 7.525 |
| 11:08 ET | 100 | 7.51 |
| 11:09 ET | 533 | 7.52 |
| 11:11 ET | 100 | 7.51 |
| 11:15 ET | 200 | 7.515 |
| 11:18 ET | 300 | 7.515 |
| 11:20 ET | 200 | 7.51 |
| 11:22 ET | 200 | 7.51 |
| 11:24 ET | 10967 | 7.49 |
| 11:26 ET | 8024 | 7.503 |
| 11:27 ET | 1363 | 7.49 |
| 11:29 ET | 399 | 7.5 |
| 11:31 ET | 845 | 7.55 |
| 11:33 ET | 1658 | 7.555 |
| 11:40 ET | 100 | 7.55 |
| 11:42 ET | 700 | 7.52 |
| 11:44 ET | 100 | 7.51 |
| 11:45 ET | 7429 | 7.47 |
| 11:47 ET | 200 | 7.49 |
| 11:51 ET | 600 | 7.475 |
| 11:56 ET | 200 | 7.48 |
| 11:58 ET | 100 | 7.47 |
| 12:00 ET | 200 | 7.47 |
| 12:02 ET | 643 | 7.47 |
| 12:03 ET | 100 | 7.47 |
| 12:05 ET | 400 | 7.48 |
| 12:07 ET | 600 | 7.47 |
| 12:09 ET | 1234 | 7.45 |
| 12:12 ET | 100 | 7.46 |
| 12:14 ET | 2270 | 7.55 |
| 12:16 ET | 1825 | 7.49 |
| 12:18 ET | 100 | 7.5 |
| 12:21 ET | 400 | 7.5075 |
| 12:23 ET | 100 | 7.515 |
| 12:25 ET | 600 | 7.505 |
| 12:27 ET | 1635 | 7.47 |
| 12:30 ET | 100 | 7.46 |
| 12:38 ET | 3650 | 7.458 |
| 12:39 ET | 100 | 7.48 |
| 12:43 ET | 400 | 7.49 |
| 12:45 ET | 500 | 7.47 |
| 12:48 ET | 100 | 7.475 |
| 12:50 ET | 700 | 7.46 |
| 12:54 ET | 100 | 7.48 |
| 12:57 ET | 259 | 7.4604 |
| 12:59 ET | 2331 | 7.515 |
| 01:01 ET | 300 | 7.5 |
| 01:03 ET | 600 | 7.5 |
| 01:06 ET | 900 | 7.48 |
| 01:08 ET | 200 | 7.5 |
| 01:10 ET | 100 | 7.51 |
| 01:15 ET | 300 | 7.505 |
| 01:17 ET | 100 | 7.505 |
| 01:19 ET | 1289 | 7.49 |
| 01:21 ET | 2138 | 7.492 |
| 01:26 ET | 800 | 7.49 |
| 01:30 ET | 100 | 7.5 |
| 01:32 ET | 2409 | 7.516 |
| 01:33 ET | 1408 | 7.515 |
| 01:37 ET | 400 | 7.5 |
| 01:44 ET | 100 | 7.515 |
| 01:48 ET | 1300 | 7.52 |
| 01:50 ET | 200 | 7.52 |
| 01:51 ET | 500 | 7.5 |
| 01:53 ET | 1600 | 7.5 |
| 01:55 ET | 100 | 7.5 |
| 01:57 ET | 400 | 7.48 |
| 02:00 ET | 206 | 7.49 |
| 02:02 ET | 400 | 7.47 |
| 02:04 ET | 239 | 7.4738 |
| 02:06 ET | 2030 | 7.47 |
| 02:08 ET | 600 | 7.48 |
| 02:09 ET | 100 | 7.48 |
| 02:11 ET | 2831 | 7.47 |
| 02:13 ET | 680 | 7.45 |
| 02:15 ET | 200 | 7.44 |
| 02:18 ET | 547 | 7.4432 |
| 02:20 ET | 643 | 7.47 |
| 02:22 ET | 515 | 7.47 |
| 02:24 ET | 1000 | 7.47 |
| 02:26 ET | 600 | 7.46 |
| 02:27 ET | 767 | 7.455 |
| 02:29 ET | 800 | 7.46 |
| 02:31 ET | 800 | 7.44 |
| 02:33 ET | 1100 | 7.43 |
| 02:36 ET | 100 | 7.43 |
| 02:38 ET | 2857 | 7.41 |
| 02:40 ET | 100 | 7.42 |
| 02:42 ET | 1300 | 7.44 |
| 02:44 ET | 600 | 7.42 |
| 02:45 ET | 100 | 7.41 |
| 02:47 ET | 862 | 7.42 |
| 02:49 ET | 100 | 7.41 |
| 02:51 ET | 2275 | 7.445 |
| 02:54 ET | 1283 | 7.43 |
| 02:56 ET | 2352 | 7.46 |
| 02:58 ET | 776 | 7.49 |
| 03:00 ET | 1031 | 7.47 |
| 03:02 ET | 2732 | 7.47 |
| 03:03 ET | 900 | 7.49 |
| 03:05 ET | 300 | 7.5 |
| 03:07 ET | 1247 | 7.47 |
| 03:09 ET | 800 | 7.47 |
| 03:12 ET | 525 | 7.47 |
| 03:14 ET | 1654 | 7.47 |
| 03:16 ET | 1500 | 7.49 |
| 03:18 ET | 8007 | 7.48 |
| 03:21 ET | 283 | 7.4704 |
| 03:23 ET | 1550 | 7.45 |
| 03:25 ET | 1264 | 7.47 |
| 03:27 ET | 100 | 7.48 |
| 03:30 ET | 546 | 7.48 |
| 03:32 ET | 1131 | 7.495 |
| 03:34 ET | 900 | 7.5 |
| 03:36 ET | 7944 | 7.495 |
| 03:38 ET | 500 | 7.49 |
| 03:39 ET | 2105 | 7.485 |
| 03:41 ET | 3463 | 7.475 |
| 03:43 ET | 1232 | 7.46 |
| 03:45 ET | 700 | 7.46 |
| 03:48 ET | 4499 | 7.475 |
| 03:50 ET | 2104 | 7.475 |
| 03:52 ET | 2462 | 7.48 |
| 03:54 ET | 3176 | 7.5 |
| 03:56 ET | 10599 | 7.51 |
| 03:57 ET | 10716 | 7.49 |
| 03:59 ET | 16519 | 7.49 |
Jun 7, 2024
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4), from 4:30PM ET on Friday Jun 07, 2024 by Dow Jones
4:30PM ET on Friday Jun 07, 2024 by Dow Jones
May 29, 2024
ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences, from 4:30PM ET on Wednesday May 29, 2024 by Dow Jones
4:30PM ET on Wednesday May 29, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Oric Pharmaceuticals Inc | 505.0M | -4.1x | --- |
Astria Therapeutics Inc | 502.5M | -3.9x | --- |
Kalvista Pharmaceuticals Inc | 509.2M | -3.8x | --- |
Replimune Group Inc | 513.7M | -2.6x | --- |
Cabaletta Bio Inc | 514.6M | -6.2x | --- |
Erasca Inc | 516.4M | -2.6x | --- |
Company Information
ORIC Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company engaged in improving patients' lives by overcoming resistance in cancer. It is developing a pipeline of clinical and discovery stage therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology and key tumor dependencies. Its clinical-stage product candidates include ORIC-114, a brain penetrant inhibitor designed to selectively target EGFR and HER2 with high potency against exon 20 insertion mutations, being developed across multiple genetically defined cancers, ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 (PRC2) via the EED subunit, being developed for prostate cancer, and ORIC-533, an orally bioavailable small molecule inhibitor of CD73, a key node in the adenosine pathway believed to play a central role in resistance to chemotherapy- and immunotherapy-based treatment regimens.
Contact Information
- Headquarters
- 240 E. Grand Ave, 2nd FloorSOUTH SAN FRANCISCO, CA, United States 94080
- Phone
- 650-388-5600
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Richard Heyman
- President, Chief Executive Officer, Director
- Jacob Chacko
- Chief Financial Officer
- Dominic Piscitelli
- Chief Medical Officer
- Pratik Multani
- Independent Director
- Mardi Dier
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $505.0M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 67.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.15 |
EPS | $-1.81 |
Book Value | $4.08 |
P/E Ratio | -4.1x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
